2017
DOI: 10.1016/j.molimm.2016.11.019
|View full text |Cite
|
Sign up to set email alerts
|

Human amniotic epithelial cells inhibit CD4+ T cell activation in acute kidney injury patients by influencing the miR-101-c-Rel-IL-2 pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 25 publications
1
21
0
Order By: Relevance
“…As amniotic epithelial stem cells exhibit characteristics such as pluripotency, immunosuppressive function and trophoblast effects, increasingly more research groups have attempted their secondary development and utilization . Our team has conducted a number of studies on HuAESCs, and we have confirmed both in vivo and in vitro that the stem cell characteristics of these cells can provide new approaches to cell therapy .…”
Section: Discussionmentioning
confidence: 75%
See 2 more Smart Citations
“…As amniotic epithelial stem cells exhibit characteristics such as pluripotency, immunosuppressive function and trophoblast effects, increasingly more research groups have attempted their secondary development and utilization . Our team has conducted a number of studies on HuAESCs, and we have confirmed both in vivo and in vitro that the stem cell characteristics of these cells can provide new approaches to cell therapy .…”
Section: Discussionmentioning
confidence: 75%
“…The separation and culture of HuAESCs were performed as described in our previous publications [1,3,4]. Briefly, human amniotic membrane was collected from the First Maternal and Child Health Centre of Shanghai, China.…”
Section: Separation and Culture Of Huaescsmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding their influence on pathological states in general, and vice versa the effect of the pathological states on their expression, both miRNAs have been reported to be involved and differentially expressed in several diseases. For example, miR-101-3p was claimed to be related to kinds of both non-malignant syndromes (multiple system atrophy [75], hepatopulmonary syndrome [76], cardiac fibroblasts [77], HBV-associated chronic hepatitis [78], Alzheimer [79], pulmonary fibrosis [80], acute kidney injury [81], gestational diabetes mellitus [82]) and, especially, malignant neoplasms [83]. Similarly, miR-22-5p is aberrantly expressed in various cancers, such as prostatic cancer [84], esophageal squamous cell carcinoma [85] and breast cancer [86], together with, among others, polyglutamine diseases such as Huntington's disease [87].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have demonstrated the therapeutic potential of hAECs in various tissue repairs, including lung injury [10, 11, 14], brain injury [20], myocardial infarction [21], kidney injury [22], and liver fibrosis [23, 24]. Nonetheless, the therapeutic effect of hAECs on diabetic wound healing is still unknown.…”
Section: Discussionmentioning
confidence: 99%